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To clarify the relationship between attention deﬁcit/hyperactivity disorder (AD/HD) and pervasive 
developmental disorders (PDD),  we investigated the common features and diﬀerences of these disor-
ders in neuropsychological proﬁles.  The subjects were 4 groups of Japanese boys aged 6 to 15 years,  
categorized by diagnosis: AD/HD (n＝20),  PDD with comorbid AD/HD (PDD＋: n＝16),  PDD without 
comorbid AD/HD (PDD－: n＝8),  and typically developing (n＝60).  We evaluated executive function 
(EF) through verbal and visuospatial memory tasks,  the Go/NoGo task,  and the color-word matching 
Stroop task.  We performed a categorical analysis to estimate the eﬀects of the 3 disorders on EF and 
a dimensional analysis to estimate the eﬀects of symptom scales on EF.  We found that the AD/HD and 
PDD＋ subjects had negative eﬀects on verbal working memory and intra-individual response vari-
ability.  The severity of these impairments was positively correlated with the inattentiveness score.  
The subjects with a PDD＋ or PDD－ diagnosis had poorer scores on interference control; the severity 
of this impairment was correlated with the PDD symptom score.  Impairments in visuospatial working 
memory were detected in the AD/HD and PDD－ groups but not in the PDD＋ group.  Impairments in 
inhibition of the pre-potent response were noted in all 3 categories.  AD/HD and PDD share neuropsy-
chological features,  though each disorder has a speciﬁc impairment pattern.  Our ﬁndings partially 
support the idea that AD/HD and PDD are on a spectrum.
Key words: attention deﬁcit/hyperactivity disorder,  pervasive developmental disorder,  executive function,  
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lthough the current Diagnostic and Statistical 
Manual of Mental Disorders-IV (DSM-IV) [1] 
does not allow the diagnosis of co-morbid attention 
deﬁcit/hyperactivity disorder (AD/HD) in patients 
with pervasive developmental disorder (PDD),  the 
symptoms of AD/HD and those of PDD often overlap.  
Therefore,  some researchers have proposed that the 
diagnosis of AD/HD be permitted in PDD patients 
[2,  3].
　 The neuropsychological bases of AD/HD and PDD 
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have been investigated by numerous researchers.  
Many previous studies have shown that inhibition,  
planning,  and working memory functions are impaired 
in individuals with AD/HD [4,  5].  Impairment of the 
inhibitory function has long been considered a primary 
neuropsychological defect in AD/HD [6].  Meta-
analytic studies have reported that impairment of the 
inhibitory function had a larger eﬀect than that of 
other impairments in executive functions [4].  However,  
in the purely inattentive type of AD/HD,  a relation-
ship between symptoms and impairment in working 
memory was reported [7].
　 Similarly,  many researchers have reported impaired 
ﬂexibility and planning functions in individuals with 
PDD [8].  With regard to the inhibitory function,  
some studies showed that inhibition of the pre-potent 
response was impaired in PDD patients.  However,  
other studies showed no deﬁnitive abnormalities in 
interference control functions,  as examined by the 
Stroop task and other similar tasks [9].  There are 
several reports related to the impaired spatial working 
memory in PDD patients,  but the results of previous 
studies were not consistent in regard to verbal work-
ing memory [10-12].
　 The disturbance in executive functions has attracted 
a signiﬁcant amount of research attention.  Considering 
the signiﬁcant overlap between the symptoms of AD/
HD and those of PDD,  the symptoms of these 2 con-
ditions may arise from dysfunctions in executive func-
tions that are common to both conditions,  as well as 
some disorder-speciﬁc dysfunctions.  Although some 
studies have investigated the diﬀerences in the execu-
tive function proﬁles among children with AD/HD,  
children with PDD and typically developing children,  
the results have been inconsistent [13-18].  One cause 
of this inconsistency may be that the co-morbidity of 
AD/HD in PDD patients was not considered in most 
studies.  Only a few studies considered AD/HD and 
PDD to be on the same disease continuum and took 
AD/HD-related symptoms in PDD patients into con-
sideration [19].
　 This study focused on the symptom overlap between 
AD/HD and PDD and aimed to clarify the relation-
ship between these 2 disorders by investigating the 
similarities and diﬀerences in their neuropsychologi-
cal features,  with a focus on inhibitory and working 
memory functions.
Subjects and Methods
　 The subjects were Japanese boys from 6 to 15 
years of age with normal intelligence: 20 boys with 
AD/HD,  24 with PDD,  and 60 typically developing 
(TD) boys as the control group.  Since previous stud-
ies showed a gender diﬀerence in some neuropsycho-
logical aspects such as inhibitory control [20],  study-
ing boys and girls separately is desirable as it enables 
better interpretation of results.  In this study,  we 
focused on boys.  The 2 patient groups had been scored 
on the Wechsler Intelligence Scale for Children-III 
(WISC-III,  Japanese version: Nihon Bunkakagakusya 
Ltd.,  Tokyo,  Japan) within a year prior to this study,  
and all members of each patient group had full-scale 
IQ (FIQ) scores of 80 or higher.  Patients with epi-
lepsy,  cerebral palsy,  severe visual impairment,  and 
past history of severe central nervous system infec-
tions or cerebral vascular diseases were excluded.
　 We recruited subjects with AD/HD or PDD from 
among the patients who visited the Okayama University 
Hospital clinic treating developmental and behavioral 
problems from April 2007 to March 2011.  The diag-
noses of AD/HD and PDD were made by experienced 
child neurologists based on the criteria of the DSM-IV 
after one to three 90-min sessions with the patients 
and their parents.  As a condition of diagnosing PDD 
not otherwise speciﬁed (PDD-NOS),  according to the 
DSM-IV the patients should have one or more appli-
cable items in at least 1 of 3 domains of autism diag-
nostic criteria: (1) qualitative impairment in social 
interaction,  (2) qualitative impairments in communi-
cation,  and (3) restricted,  repetitive,  and stereotyped 
patterns of behavior,  interests,  and activities.
　 In the patients diagnosed with PDD,  we also 
evaluated AD/HD-related symptoms according to the 
DSM-IV.  The PDD group (n＝24) consisted of 3 boys 
with autistic disorder,  3 with Aspergerʼs disorder,  
and 18 with PDD not otherwise speciﬁed (NOS).  
Sixteen of these 24 patients (3 with autistic disorder,  
2 with Aspergerʼs disorder,  and 11 with PDD-NOS) 
met the AD/HD diagnostic criteria.
　 When diagnosing AD/HD,  we also evaluated PDD-
related symptoms based on the DSM-IV.  If a patient 
could be diagnosed as having PDD,  we gave priority 
to the diagnosis of PDD over the diagnosis of AD/HD.  
The AD/HD group (n＝20) consisted of 4 boys with 
combined-type AD/HD and 16 with predominantly 
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inattentive type.  There were no patients with pre-
dominantly hyperactive-impulsive type AD/HD.
　 The TD group consisted of 60 healthy boys attend-
ing elementary schools or junior high schools in 
Okayama prefecture.  They participated in this study 
as volunteers.  We conﬁrmed that they had no history 
of developmental or behavioral problems by means of 
a parent-reported questionnaire at the time of partici-
pation.  TD boys were excluded when their scores on 
the Autistic Spectrum Screening Questionnaire,  
Japanese version (ASSQ-R) or the revised AD/HD 
rating scale (AD/HD-RS) were outliers.
　 If patients were prescribed methylphenidate (MPH),  
we had the patients not take the MPH for 24h before 
they underwent the neuropsychological tests.  We did 
not restrict other medications.  Written informed 
consent was obtained from all participants and/or 
their parents at the time of this study.  After partici-
pating in this study,  all subjects received a book cou-
pon as an expression of our gratitude.  This study was 
approved by the Ethical Committee of the Okayama 
University Graduate School of Medicine,  Dentistry 
and Pharmaceutical Sciences.
　 Neuropsychological tasks. We administered 
5 types of memory tasks and 2 types of inhibition tasks 
to each subject.  To evaluate memory function in detail,  
we used 3 verbal memory tasks and 2 visuospatial 
memory tasks.  One of the verbal tasks and one of the 
visuospatial tasks were relatively simple passive tasks,  
and the remaining memory tasks were dual tasks 
involving both storage and active processing compo-
nents of memory.  Of the 2 inhibition tasks,  one assessed 
inhibition of the pre-potent response and the other 
assessed interference control.  All tasks other than the 
digit span test were prepared using E-Prime 1.0 neu-
ropsychological software (Psychology Software Tools,  
Inc.,  Sharpsburg,  PA,  USA) and were administered 
on a laptop computer with a 12-inch LCD touch screen 
panel (Lenovo Thinkpad x60 tablet).  Subject responses 
were collected using a stylus pen attached to the 
notebook computer or the buttons on a Serial Response 
Box (SR Box),  which was included with the E-Prime 
software package.  Each subject was examined in a 
quiet room while he was seated on a chair.  The note-
book computer and the SR Box were placed in front of 
the subject.
1. Digit span task
　 As one of the verbal memory tasks,  we used the 
digit span subtest of the WISC-III.  Forward span was 
administered as a simple passive task,  and backward 
span as a complex active task.  If a subject had been 
given the WISC-III within 1 year,  we used the digit 
span score from the previous test session in this study.
2. Reading span test (RST)
　 As another measure of verbal working memory,  the 
Reading Span Test (RST) [21] was administered.  We 
prepared our own age-appropriate sentences for the 
RST.  The “target word” was placed at random posi-
tions in the stimulus sentences.  The subject was 
instructed not only to read each sentence aloud but 
also to memorize a target word underlined in red.  
Several sentences were presented one after another in 
a set.  After reading all of the sentences in a set,  the 
subject was asked to recall all of the target words 
included in the set.  The span level indicated the num-
ber of sentences in each set.  This started at 2 and 
could increase to as high as 5.  When a subject passed 
3 out of 5 trials at one span level,  he proceeded to the 
next span level.  Every time a subject passed a span 
level,  he received 1 point.  If a subject gave 2 correct 
answers out of 5 trials,  he received 0.5 point at that 
span level.  The evaluated score was the span score,  
deﬁned as the sum of these points (0 to 5 points).
3. Visuospatial span task (VST)
　 To measure visuospatial short-term memory,  we 
used the visuospatial span task (VST) [22].  Circles 
(memory stimuli) were presented one at a time in a 4
×4 matrix on the computer screen.  Each stimulus 
was displayed for 2 s on the screen.  After all stimuli 
in each trial were presented,  the subject was 
instructed to touch the locations in which these mem-
ory stimuli had appeared in an empty matrix on the 
touch screen,  using a stylus pen.  The span level 
indicated the number of circles in each set.  This 
started at 2,  increased after 2 trials,  and ranged up 
to a maximum of 9.  The test terminated when the 
subject erred in both trials at a particular span level.  
The evaluated score was the span score,  deﬁned as the 
highest span level in which the subject passed at least 
one trial (0 to 9 points).
4. Visuospatial working memory test (VWT)
　 To measure visuospatial working memory,  we used 
the visuospatial working memory test (VWT) [23].  In 
this complex dual task,  the subject was presented 
with 3 circles serially in contiguous cells in a 4×4 
matrix and asked to immediately make an alignment 
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judgment in which they had to decide whether the 
positions of the 3 circles were along the same line.  
After several alignment judgment tasks,  the subject 
was directed to recall the position of the last circles 
in each set.  The span level indicates the number of 
alignment judgment tasks in each set.  When a subject 
passed 3 out of 5 trials at the same span level,  that 
subject proceeded to the next span level.  The span 
level started at 2 and could increase as high as 5.  The 
evaluated score was the span score,  deﬁned as the 
highest span level in which the subject passed 3 out of 
5 trials (0 to 5 points).
5. Go/NoGo task (Go/NoGo)
　 To examine inhibition of the pre-potent response,  
we used the Go/NoGo task [24].  Three pictures were 
repeatedly presented at random on the screen.  One of 
the 3 was the “NoGo” stimulus,  and the other 2 were 
the “Go” stimuli.  Each stimulus was displayed for 
500ms followed by a random interval (blank screen) that 
was either 1,000,  1,500,  or 2,000ms.  This task con-
sisted of 3 blocks,  and each block consisted of 100 
trials.  The subject took a 10-sec break between each 
block.  Forty-ﬁve out of 300 stimuli were “NoGo” 
stimuli.  The subject was instructed to push the button 
as fast as possible when a “Go” stimulus was pre-
sented,  and not to respond to a “NoGo” stimulus.
　 The evaluated scores were the rate of omission 
errors (ｵ omission),  the rate of commission errors 
(ｵ commission),  the mean reaction time (mean RT) to 
the Go stimulus,  and the coeﬃcient of variation (CV).  
The CV was calculated according to the following 
formula:
(standard deviation of RT to Go stimuli)/(mean 
RT to Go stimuli)
　 Responses with reaction times of less than 110ms 
were considered to be anticipation errors and were 
omitted from the analysis.  Though we intended to 
program E-Prime to set the window time for response 
acquisition at 1,400ms,  the actual window time was 
500ms due to an inadequacy of the program.
6. Color-word matching stroop task (cwmStroop)
　 To examine interference control competence,  we 
used the color-word matching Stroop task (cwmStroop) 
[25].  Two rows of letters appeared on the screen.  
Letters in the upper row were printed in red,  blue,  
yellow,  or green font.  Letters in the lower row con-
sisted of color names in Japanese,  namely,  “あか
[aka] (red), ” “あお[ao] (blue), ” “きいろ[kiiro] (yel-
low), ” and “みどり[midori] (green)” displayed in black 
font.  The letters in the lower row were presented 
100ms after those in the upper row.  Subjects were 
required to judge whether the font color of the letters 
in the upper row corresponded to the color word in the 
lower row,  and pushed one of 2 buttons (“1” for yes,  
“2” for no) as fast as possible.  These stimuli were 
presented for a maximum of 4sec until a subject 
responded.
　 For incongruent trials,  the top row consisted of the 
color names printed in diﬀerent colors.  For congruent 
trials,  the top row consisted of the color names printed 
in the same color.  For the neutral condition,  the top 
row consisted of “XXX. ” This task consisted of 4 
blocks,  with each block consisting of 30 trials (10 
trials in each of the 3 conditions).  After each trial,  a 
blank screen was displayed for 100ms.  The subject 
took a 30-sec break between each block.  In half of the 
trials in each condition,  the color of the letters in the 
upper row corresponded to the color names in the 
lower row.  The evaluated scores were the ratio of 
correct answers and the mean RT in the incongruent 
condition.
　 Questionnaires. We asked the parents of all 
participants to ﬁll out 3 questionnaires: the Autistic 
Spectrum Screening Questionnaire,  Japanese version 
(ASSQ-R) [26,  27],  the AD/HD Rating Scale-Revised 
(AD/HD-RS-R),  and our original questionnaire on 
problems with vision or hearing and past history of 
diseases or developmental problems.  The ASSQ-R is 
composed of 27 questions pertaining to behavioral 
problems that are common among patients with PDD.  
Each item is rated on a 3-point scale,  ranging from 0 
(normal) and 1 (slightly abnormal) to 2 (deﬁnitely 
abnormal).  The total ASSQ-R score ranges from 0 to 
54 points.
　 For the AD/HD-RS-R,  we translated the original 
AD/HD Rating Scale-IV for parents [28] into 
Japanese,  and added some typical examples of abnor-
mal behavior related to each item on the questionnaire 
to help parents answer.  The AD/HD-RS-R is com-
posed of nine items related to inattention and nine 
items related to hyperactivity and impulsivity.  Each 
item is rated on a 4-point scale,  ranging from 0 (never 
or rarely) to 3 (very often).  The total AD/HD-RS-R 
score ranges from 0 to 54 points and includes an inat-
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tention score (0 to 27 points) and a hyperactivity/
impulsivity score (0 to 27 points).
　 Data analysis. We analyzed the relations between 
the clinical symptoms and the scores on our test bat-
tery using 2 approaches: the categorical approach and 
the dimensional approach.  In the categorical approach,  
the participants were divided into 4 groups: PDD 
children with AD/HD symptoms that met the DSM-IV 
criteria of AD/HD (PDD＋),  PDD children without 
AD/HD symptoms (PDD－),  children with AD/HD 
only (AD/HD),  and TD children.  Each disorder cat-
egory was deﬁned as a dummy variable; namely,  a 
subject was assigned a value of 1 if he belonged to the 
particular disorder category (AD/HD,  PDD＋,  PDD－) 
and 0 if he did not.  All 3 of these variables were 0 in 
TD (the control group).  We performed a standard-
ized multiple linear regression analysis with these 3 
dummy variables and age as independent variables and 
the scores of each task as dependent variables.
　 We used a one-way analysis of variance (ANOVA) 
to compare mean age among the 4 groups and to com-
pare mean IQs among the 3 patient groups (AD/HD,  
PDD＋,  and PDD－),  followed by t-test with the 
Bonferroni correction as a post-hoc multiple compari-
son.
　 In the dimensional approach,  we used the number 
of items corresponding to the clinical symptoms listed 
in the DSM-IV diagnostic criteria of AD/HD or 
autistic disorder as a symptom scale.  The symptom 
scale for AD/HD consists of 2 parts: a scale of inat-
tentive symptoms and a scale of hyperactive/impulsive 
symptoms.  We performed a standardized multiple 
linear regression analysis with the age of subjects and 
the 3 symptom scales (inattentive,  hyperactive/impul-
sive,  PDD) as independent variables and the scores of 
each task as dependent variables.  For the TD group,  
we did not clinically evaluate behavior based on the 
DSM-IV.  Instead,  we calculated 3 symptom scales 
based on the AD/HD-RS-R and ASSQ-R scores.  
Because 9 inattentive symptoms are listed in the 
DSM-IV and the maximum inattention score on the 
AD/HD-RS-R is 27,  the scale of inattentive symp-
toms was calculated according to the following for-
mula:
9× (inattention score of AD/HD-RS-R)/27
　 In the same way,  the scale of hyperactive/impul-
sive symptoms was calculated according to the follow-
ing formula:
9× (hyperactivity/impulsivity score of AD/
HD-RS-R)/27
　 Because 12 autism symptoms are listed in the 
DSM-IV and the maximum score on the ASSQ-R is 
54,  the scale of PDD symptoms was calculated 
according to the following formula:
12× (total score of ASSQ-R)/54
　 Each result of these formulas was rounded oﬀ to 
the nearest integer.  All statistical analyses were 
performed using SPSS version 17 for Windows.
Results
　 The mean and standard deviation (SD) of age,  
verbal IQ (VIQ),  performance IQ (PIQ),  and full-scale 
IQ (FIQ) in each group as well as handedness and 
details of medication at the time of the present exami-
nation are shown in Table 1.  There was no signiﬁcant 
diﬀerence in age among the 4 groups,  and no signiﬁ-
cant diﬀerence in VIQ,  PIQ,  and FIQ among the 3 
patient groups.  Additionally,  the mean,  median,  and 
range of the 3 symptom scales (i.e.,  inattention,  
hyperactivity/impulsivity,  and PDD) of each group 
are shown in Table 2.
　 Eﬀects of categorical factors on executive 
functions. With 3 dummy variables and age as 
independent variables and the scores of each task as 
dependent variables,  the adjusted coeﬃcients of deter-
mination (R2) and standardized partial regression 
coeﬃcients (β) of multiple regression equations were 
calculated and are shown in Table 3.
1. Verbal working memory
　 No signiﬁcant eﬀect of diagnostic category on the 
forward recall scores in the digit span task was found.  
The AD/HD group showed signiﬁcantly lower back-
ward recall scores (β＝－0.222,  p＝0.012),  and the 
PDD＋ groups tended to show lower backward recall 
scores (β＝－0.171,  p＝0.052).
　 In the RST,  the AD/HD subjects produced sig-
niﬁcantly lower span scores (β＝－0.220,  p＝0.010),  
as did the PDD＋ subjects (β＝－0.266,  p＝0.002).
2. Visuospatial working memory
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　 On the VST,  the boys with AD/HD had signiﬁ-
cantly lower span scores (β＝－0.178,  p＝0.045).  A 
tendency for lower span scores on the VST was also 
observed in the PDD＋ group (β＝－0.162,  p＝0.068) 
and the PDD－ group (β＝－0.164,  p＝0.063).
　 On the VWT,  the boys with AD/HD had signiﬁ-
cantly lower span scores (β＝－0.188,  p＝0.01),  as 
did the children with PDD－ (β＝－0.200,  p＝0.006).  
The PDD＋ group tended to have lower span scores 
(β＝－0.137,  p＝0.057).
3. Inhibition of the pre-potent response and inter-
ference control
　 With respect to the Go/NoGo task,  the subjects 
with AD/HD (β＝0.282,  p＝0.005),  PDD＋ (β＝
0.239,  p＝0.016),  or PDD－ (β＝0.233,  p＝0.018) 
made signiﬁcantly more commission errors.  However,  
the diagnostic category had no eﬀect on the percentage 
of omission errors.  The mean RT tended to be shorter 
in the AD/HD group (β＝－0.167,  p＝0.066) and the 
PDD＋ group (β＝－0.174,  p＝0.056).  The CV was 
signiﬁcantly higher in the AD/HD (β=0.231,  p＝
0.018) and PDD＋(β=0.382,  p＜0.001) groups.
　 For the cwmStroop task,  the PDD－ subjects tended 
to have a reduced percentage of correct answers in the 
incongruent condition (β＝－0.178,  p＝－0.057).  The 
subjects with PDD＋ showed signiﬁcantly prolonged 
mean RTs in the incongruent condition (β=0.221,  p 
=0.001).
　 Eﬀects of symptom scales on executive func-
tions. With the 3 symptom scales (inattentive,  
hyperactive/impulsive,  and PDD) and age as indepen-
dent variables and the scores of each task as depen-
dent variables,  we calculated the adjusted coeﬃcients 
of determination (R2) and standardized partial regres-
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Table 1　 Chronological ages,  medication,  and IQs of the subjects
AD/HD PDD＋ PDD－ TD
N (Left-handed) 20 (1) 16 (2) 8 (0) 60 (4)
Age (years) 10.3±2.1 9.7±1.9 11.2±2.4 10.1±2.4
MPH 7 5 0 0
SSRI 1 0 1 0
Antipsychotics 1 1 2 0
VIQ 95.7±9.8 94.4±8.7 94.9±9.5 not done
PIQ 102.1±10.2 94.3±9.8 95.8±9.3 not done
FIQ 98.7±8.7 93.9±8.4 95.0±7.8 not done
AD/HD,  attention deﬁcit/hyperactivity disorder; PDD＋,  pervasive developmental disorder with comorbid AD/HD; PDD－,  pervasive 
developmental disorder without comorbid AD/HD; TD,  typical development; MPH,  methylphenidate; SSRI,  selective serotonin reuptake 
inhibitors; VIQ,  verbal IQ; PIQ,  performance IQ; FIQ,  full-scale IQ.
Table 2　 Symptom scale scores of each group
Symptom
scales AD/HD PDD＋ PDD－ TD
inattentive
mean 7.3 7.1 2.8 1.2
median 7.0 7.0 2.5 1.0
range 6.0-9.0 6.0-9.0 0-5.0 0-3.7
hyperactive/impulsive
mean 3.1 3.5 0.9 0.6
median 2.5 3.5 0.5 0.3
range 0-9.0 0-7.0 0-3.0 0-3.3
PDD
mean 0.6 4.6 4.0 0.6
median 0 4.0 3.5 0.2
range 0-3.0 2.0-9.0 3.0-6.0 0-2.2
AD/HD,  attention deﬁcit/hyperactivity disorder; PDD,  pervasive developmental disorder; PDD＋,  pervasive developmental disorder with 
comorbid AD/HD; PDD－,  pervasive developmental disorder without comorbid AD/HD; TD,  typical development.
sion coeﬃcients (β) of multiple regression equations; 
the results are shown in Table 4.
1. Verbal working memory
　 In the digit span task,  no signiﬁcant eﬀect of any 
of the 3 symptom scales on forward recall scores was 
found.  In contrast,  negative associations were noted 
between the score on the inattentive symptom scale and 
the backward recall score on the digit span task as 
well as the span score in the RST.  As the inattentive 
symptom scale score increased,  the backward recall 
score on the digit span task (β＝－0.335,  p＝0.01) 
and the span score in the RST (β＝－0.408,  p＝
0.001) decreased signiﬁcantly.  The other 2 symptom 
scales (hyperactive/impulsive and PDD) had no eﬀect 
on the backward recall score or the span score in the 
RST.
2. Spatial working memory
　 No signiﬁcant eﬀect of any of the 3 symptom scales 
on the span score of the VST or the VWT was found.
3. Inhibition of the pre-potent response and inter-
ference control
　 Our results indicated a positive association between 
the inattentive symptom scale score and the CV in the 
Go/NoGo task.  As the inattentive symptom scale 
score increased,  the CV increased signiﬁcantly (β＝
0.351,  p＝0.015).  In addition,  as the inattentive 
symptom scale score increased,  the ｵ commission in 
the Go/NoGo task tended to increase (β＝0.248,  p＝
0.094).  No signiﬁcant eﬀect of the inattentive symp-
tom scale on the other scores in the Go/NoGo task 
was noted.  There was no signiﬁcant eﬀect of the 
hyperactivity/impulsivity symptom scale or the PDD-
related symptom scale on the scores in the Go/NoGo 
task.
　 No signiﬁcant eﬀect of the inattentive or hyperac-
tivity/impulsivity symptom scale on the scores in the 
cwmStroop task was noted.  We found a positive 
association between the PDD-related symptom scale 
score and the mean RT in the cwmStroop task.  As the 
PDD-related symptom scale score increased,  the mean 
RT in the incongruent condition increased signiﬁ-
cantly (β＝0.176,  p＝0.009).
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Table 3　 Eﬀects of diagnostic categories on executive functions
Dependent variables AdjustedR2





Forward recall 0.357＊＊ 0.598＊＊ 0.035　　 －0.125　　 －0.053　　
Backward recall 0.275＊＊ 0.498＊＊ －0.222＊　 －0.171＃　 －0.080　　
RST
Span score 0.356＊＊ 0.538＊＊ －0.220＊＊ －0.266＊　 －0.094　　
VST
Span score 0.265＊＊ 0.502＊＊ －0.178＊　 －0.162＃　 －0.164＃　
VWT
Span score 0.513＊＊ 0.707＊＊ －0.188＊＊ －0.137＃　 －0.200＊＊
Go/NoGo
% commission 0.095＊＊ －0.030　　 0.282＊＊ 0.239＊　 0.233＊　
% omission 0.462＊＊ －0.687＊＊ －0.015　　 0.056　　 －0.004　　
Correct mean RT 0.230＊＊ －0.467＊＊ －0.167＃　 －0.174＃　 －0.038　　
Correct CV 0.122＊＊ 0.008　　 0.231＊　 0.382＊＊ 0.083　　
cwmStroop
Incongruent accuracy 0.172＊＊ 0.419＊＊ 0.006　　 －0.118　　 －0.178＃　
Incongruent mean RT 0.631＊＊ －0.766＊＊ 0.002　　 0.221＊　 0.102　　
＊＊p＜0.01,  ＊p＜0.05,  ＃p＜0.10
R2,  coeﬃcient of determination; RST,  reading span task; VST,  visuo-spatial span task; VWT,  visuo-spatial working memory test; RT,  
reaction time; CV,  coeﬃcient of variation.
Discussion
　 Here we investigated executive functions,  focusing 
on working memory and inhibition control,  both of 
which have been reported to be associated with AD/
HD [4].  In addition to subjects with AD/HD,  we 
also evaluated the symptoms of AD/HD according to 
DSM-IV criteria in subjects with PDD.  We classiﬁed 
the subjects with PDD into a PDD＋ group with AD/
HD symptoms and a PDD－ group without.  In this 
way,  we could investigate the relationships between 
executive functions and AD/HD-related symptoms in 
subjects with PDD as well as those with AD/HD.
　 Verbal working memory was impaired in the sub-
jects with AD/HD symptoms (i.e.,  the AD/HD and 
PDD＋ groups).  Further,  the more inattentive symp-
toms a subject had,  the more likely it was that the 
subjectʼs verbal working memory was disturbed.  
These results indicated a relationship between AD/
HD-related symptoms (inattention scores) and impair-
ment of verbal working memory.  Considering that a 
previous study showed a high co-morbidity of reading 
disability in patients with AD/HD [29],  it is neces-
sary to take into account the possible eﬀect of reading 
ability on the RST scores.  In the RST,  a subjectʼs 
ability to remember words is expected to decrease 
when the subject has reading diﬃculty.  However,  in 
the present study the score on the backward digit span 
task,  which does not involve reading letters,  was also 
found to be correlated with AD/HD symptoms or the 
diagnosis of AD/HD.  We therefore suspect that the 
inattentive symptoms themselves are related to 
impairment of the verbal working memory function.  
Other recent studies have also shown a relationship 
between verbal working memory and inattention [30].
　 As for spatial working memory tasks,  the boys 
diagnosed with AD/HD had signiﬁcantly lower span 
scores on both the VST and the VWT.  The boys with 
the diagnosis of PDD－ had signiﬁcantly lower span 
scores on the VWT,  but only marginally lower span 
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Table 4　 Eﬀects of symptom scales on executive functions
Dependent variables AdjustedR2





Forward recall 0.346＊＊ 0.609＊＊ －0.063　　 0.048 －0.072　　
Backward recall 0.280＊＊ 0.507＊＊ －0.335＊　 0.091 0.079　　
RST
Span score 0.373＊＊ 0.564＊＊ －0.408＊＊ 0.165 －0.038　　
VST
Span score 0.235＊＊ 0.451＊＊ －0.195　　 0.048 －0.012　　
VWT
Span score 0.484＊＊ 0.683＊＊ －0.179　　 0.000 －0.029　　
Go/NoGo
% commission 0.053　　 －0.007　　 0.248＃　 －0.003 0.099　　
% omission 0.466＊＊ －0.711　　 0.116　　 －0.126 －0.005　　
Correct mean RT 0.224＊＊ －0.478＊＊ －0.102　　 －0.093 －0.036　　
Correct CV 0.110＊　 －0.016　　 0.351＊　 －0.094 0.154　　
cwmStroop
Incongruent accuracy 0.151＊＊ 0.426＊＊ －0.058　　 0.150 －0.099　　
Incongruent mean RT 0.630＊＊ －0.774＊＊ 0.112　　 －0.033 0.176＊＊
＊＊p＜0.01,  ＊p＜0.05,  ＃p＜0.10
R2,  coeﬃcient of determination; RST,  reading span task; VST,  visuo-spatial span task; VWT,  visuo-spatial working memory test; RT,  
reaction time; CV,  coeﬃcient of variation.
scores on the VST.  In contrast,  the boys with PDD＋ 
(i.e.,  PDD＋AD/HD) showed only slightly lower span 
scores on both the VST and VWT.  Willcutt et al.  
performed a meta-analysis regarding spatial working 
memory in patients with AD/HD [4].  Six of the 8 
studies analyzed indicated that patients with AD/HD 
had signiﬁcantly lower scores than those in the control 
group,  and the 6 studies showed a medium weighted 
mean eﬀect size.  These studies yielded results similar 
to ours,  and thus it is likely that AD/HD is related to 
the impairment of spatial working memory.
　 Several research groups have studied spatial work-
ing memory in patients with PDD using the spatial 
working memory task from the Cambridge Neuropsy-
chological Test Automated Battery (CANTAB) [17,  
19,  31,  32].  With the exception of the study by 
Happe et al.  [17],  the studies found a signiﬁcant rela-
tion between PDD and impairment of spatial working 
memory.  Among them,  Sinzig et al.  [19] adopted the 
same diagnostic categories that we used.  Their ﬁnd-
ings indicated that their 2 patient groups (corre-
sponding to our AD/HD and PDD－ groups) showed 
more errors than the control group,  but the remaining 
patient group (corresponding to our PDD＋ group) 
showed no signiﬁcant abnormalities.  In our study and 
theirs,  a diagnosis of PDD＋ did not result in signiﬁ-
cantly lower VST or VWT scores.  Thus,  it seems 
likely that the degree of spatial working memory 
impairment in the present PDD＋ group is milder than 
that in the AD/HD group or the PDD－ group.  
Although the data are diﬃcult to interpret,  it is inter-
esting to note that the present subjects with PDD＋ 
(who have symptoms of both AD/HD and PDD) 
showed milder impairment of spatial working memory 
than the other 2 groups.  The pathological conditions 
of AD/HD and PDD may interact with each other in 
a complicated manner.
　 The ｵ commission in the Go/NoGo task is a mea-
sure of the inhibitory function of the pre-potent 
response.  Several studies of Go/NoGo task scores 
among typically developing children and patients with 
AD/HD or PDD have been reported [14,  17,  19]:  
all of them found signiﬁcantly higher rates of commis-
sion errors or false alarms in patients with AD/HD,  
but their results with regard to PDD were not com-
patible.  In our study,  a diagnosis in any of the 3 cat-
egories,  AD/HD,  PDD＋,  or PDD－,  signiﬁcantly 
increased the ｵ commission.  The standardized partial 
regression coeﬃcients were fairly similar among the 3 
diagnostic categories as well.  Thus,  impairment of the 
inhibitory function for the pre-potent response is 
likely to be commonly associated with both AD/HD 
and PDD.  Many previous studies have reported that 
patients with AD/HD show high rates of omission 
errors [4],  but in the present study neither the AD/
HD diagnosis nor the PDD diagnosis had any eﬀect on 
the ｵ omission.  Because of the short time window for 
response acquisition in our Go/NoGo task,  responses 
with reaction times longer than 500ms were errone-
ously judged as omission errors.  This may have led to 
our negative result.
　 The reaction time CV is one of the indexes used to 
measure intra-individual variability of responses.  The 
Go/NoGo task and the continuous performance test 
have been widely used to examine the high levels of 
intra-individual variability in patients with AD/HD 
[33].  In the present study,  the CV was higher in both 
the AD/HD group and the PDD＋ group compared to 
the TD group,  and as the inattentive symptom scale 
score increased,  the CV increased signiﬁcantly.  This 
result suggests that inattentive symptoms may be 
related to increased intra-individual response vari-
ability.
　 Regarding the cwmStroop task,  the PDD＋ sub-
jects showed signiﬁcantly prolonged mean RTs,  and 
the PDD－ subjects achieved low scores in the incon-
gruent condition,  with marginal signiﬁcance.  In the 
dimensional approach,  as the PDD-related symptom 
scale scores increased,  the mean RTs in the incongru-
ent condition increased signiﬁcantly.  These results 
indicate that an impairment of the cognitive process 
tapped by the cwmStroop task may be related to 
symptoms of PDD.  However,  most previous studies 
that used the classical Stroop task found no impair-
ment in interference control in patients with PDD 
[9].
　 In patients with AD/HD,  on the other hand,  many 
previous studies using the classical Stroop task found 
lower scores and longer reaction times [34].  In the 
cwmStroop task adopted in the present study,  sub-
jects matched 2 attributes of diﬀerent stimuli.  In 
contrast,  subjects performing the classical Stroop 
task generate a verbal response to match one attribute 
of a stimulus.  Consequently,  the response preparation 
process and interference control process are aﬀected 
mutually and are not separable in the classical Stroop 
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task,  whereas the 2 processes are separated in the 
cwmStroop [35].  CwmStroop is more suitable to 
purely assess interference control ability,  because the 
results of the classical Stroop task reﬂect both inter-
ference control and motor preparation and the inhibi-
tion of motor responses.  This may be the basis of the 
discrepancy between the results of our study and those 
of previous studies using the classical Stroop task.
　 Adams et al.  reported that patients with PDD 
showed signiﬁcant impairment on a modiﬁed ﬂanker 
resistant to distractor task that assesses interference 
control function; these patients showed intact pre-
potent response inhibition on the stop-signal response 
inhibition task [36].  Those results and our present 
ﬁndings indicate that impairment of interference con-
trol at a conceptual level in patients with PDD may 
play an important role in the cognitive processes of 
patients with PDD.
　 The relationships between scores on the test bat-
teries and our 3 diagnostic categories are shown in 
Fig. 1.  The patients with AD/HD symptoms (i.e.,  the 
AD/HD and PDD＋ groups) showed impairments in 
verbal working memory and increased intra-individual 
variability.  On the other hand,  the patients with PDD 
symptoms (the PDD and PDD＋ groups) showed 
impairments in interference control.  Accordingly,  
impairments in response inhibition were common fea-
tures in AD/HD and PDD traits.
　 From a neuropsychological perspective,  AD/HD 
and PDD have some common features,  though each 
disorder has a speciﬁc impairment pattern,  and PDD＋ 
often shows overlap with some characteristics of PDD 
and some of AD/HD.  However,  it seems that PDD＋ 
is not a simple combination of AD/HD and PDD in 
terms of cognitive functions.  Impairments of visuospa-
tial working memory were observed in the present 
AD/HD and PDD groups but not in the PDD＋ 
groups.  Further studies focused on the other cogni-
tive functions and the symptoms of individuals with 
PDD＋ are required to clarify the details of this 
interesting group.
　 There are some study limitations.  We examined 
only working memory and inhibitory functions.  Other 
executive functions such as “planning, ” which could 
relate to both AD/HD and PDD [4,  8],  and “set 
shifting, ” which could relate to PDD [8],  should be 
researched in the future using both categorical and 
dimensional approaches.  Secondly,  many of our sub-
jects were being treated with medications.  We 
restricted the use of methylphenidate (MPH) for 24h 
before the neuropsychological testing,  because MPH 
is thought to improve the executive functions of 
patients with AD/HD [37].  The neuropsychological 
eﬀects of risperidone (RIS),  which is often prescribed 
to patients with PDD,  remain unclear,  though it was 
reported that RIS improved the function of working 
memory in patients with PDD [38].  The neuropsy-
chological eﬀects of selective serotonin reuptake 
inhibitors are also unknown.  In this study,  although 
we eliminated the short-term eﬀects of MPH,  the 
possibility remained that executive functions may have 
been aﬀected by other medications.
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